Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operative management of isolated posterior cruciate ligament injuries improves stability and reduces the incidence of secondary osteoarthritis: a systematic review.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2021
Same author

How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2018
Same author

Added diagnostic value and impact on antimicrobial therapy of 16S rRNA PCR and amplicon sequencing on resected heart valves in infective endocarditis: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Performance of three generations of Xpert MRSA in routine practice: approaching the aim?

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Characterisation of Staphylococcus aureus isolates from bloodstream infections, Democratic Republic of the Congo.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Ceftazidime: comparative in-vitro study.

L Verbist1, J Verhaegen

  • 1Diagnostic Microbiology Laboratory, St Rafaël Hospital, University of Leuven, B-3000 Leuven, Belgium.

The Journal of Antimicrobial Chemotherapy
|October 7, 2009
PubMed
Summary
This summary is machine-generated.

Ceftazidime demonstrates potent antibacterial activity, particularly against Pseudomonas aeruginosa and Enterobacteriaceae. This cephalosporin antibiotic remains effective even against strains resistant to other beta-lactams.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Ceftazidime is a third-generation cephalosporin antibiotic.
  • Assessing the in vitro activity of antibiotics is crucial for guiding clinical treatment.
  • Understanding resistance patterns is vital for effective antimicrobial stewardship.

Purpose of the Study:

  • To evaluate the in vitro antibacterial spectrum and potency of ceftazidime.
  • To compare ceftazidime's activity against key bacterial pathogens, including resistant strains.
  • To determine the efficacy of ceftazidime against Pseudomonas spp. and Enterobacteriaceae.

Main Methods:

  • In vitro susceptibility testing of ceftazidime against a large collection of bacterial isolates.
  • Determination of minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs).
  • Evaluation of ceftazidime activity against strains with acquired and natural resistance to other beta-lactam antibiotics.

Main Results:

  • Ceftazidime exhibited high activity against Haemophilus influenzae, streptococci (excluding enterococci), and Enterobacteriaceae.
  • It was the most potent beta-lactam antibiotic against Pseudomonas spp., including Pseudomonas aeruginosa.
  • Ceftazidime maintained significant activity against bacteria resistant to other beta-lactams.

Conclusions:

  • Ceftazidime is a highly effective antibiotic against a broad range of Gram-negative bacteria, notably Pseudomonas aeruginosa.
  • Its efficacy extends to resistant strains, making it a valuable therapeutic option.
  • The study confirms ceftazidime's position as a key antibiotic in treating infections caused by susceptible pathogens.